144 related articles for article (PubMed ID: 16435599)
41. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
Bays HE; Davidson M; Jones MR; Abby SL
Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
[TBL] [Abstract][Full Text] [Related]
42. Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemia.
Stein EA; Amerena J; Ballantyne CM; Brice E; Farnier M; Guthrie RM; Harats D; Ma PT; Le Maulf F; Melezínková H; Gold A; Sager P
Am J Cardiol; 2007 Nov; 100(9):1387-96. PubMed ID: 17950795
[TBL] [Abstract][Full Text] [Related]
43. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
44. Lipid treatment assessment project II in Thailand (LTAP-II Thailand).
Nitiyanant W; Sritara P; Deerochanawong C; Ngarmukos P; Koanantakul B
J Med Assoc Thai; 2008 Jun; 91(6):836-45. PubMed ID: 18697382
[TBL] [Abstract][Full Text] [Related]
45. Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival.
Leeper NJ; Ardehali R; deGoma EM; Heidenreich PA
Circulation; 2007 Aug; 116(6):613-8. PubMed ID: 17664373
[TBL] [Abstract][Full Text] [Related]
46. Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia.
Svilaas A; Strandberg T; Eriksson M; Hildebrandt P; Westheim A
Scand Cardiovasc J; 2008 Aug; 42(4):279-87. PubMed ID: 18609053
[TBL] [Abstract][Full Text] [Related]
47. [Biochemical evaluation of the results of lipid regulating treatment in France].
Ferrières J; Lablanche JM; Pouchain D; Girerd X; Krempf M; Nguyen G; Glanddier PY
Arch Mal Coeur Vaiss; 2005 Jan; 98(1):58-62. PubMed ID: 15724421
[TBL] [Abstract][Full Text] [Related]
48. A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care.
Kedward J; Dakin L
Br J Gen Pract; 2003 Sep; 53(494):684-9. PubMed ID: 15103875
[TBL] [Abstract][Full Text] [Related]
49. Don't trust an LDL over 70?
Aronow WS
Geriatrics; 2004 May; 59(5):12-3. PubMed ID: 15152729
[No Abstract] [Full Text] [Related]
50. Stricter cholesterol guidelines broaden indications for the 'statin' drugs.
Capriotti T
Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600
[No Abstract] [Full Text] [Related]
51. [Inadequate management of dyslipidaemic patients in France. Results of the Odyssée study].
Ferrières J; Elbaz M; Maupas E; Carriè D; Puel J
Arch Mal Coeur Vaiss; 2004 Mar; 97(3):187-93. PubMed ID: 15106741
[TBL] [Abstract][Full Text] [Related]
52. The primary target. Taking aim at LDL levels to prevent cardiovascular disease.
Mason CM
Adv Nurse Pract; 2007 Dec; 15(12):55-8. PubMed ID: 20014676
[No Abstract] [Full Text] [Related]
53. [Evaluation and care of patients with type Ii diabetes regarding recommendations concerning cardiovascular risk factors and adherence to values in general medicine in the Grand Duchy of Luxembourg].
Stein R; Aubart-Schuller M; Vandenberghe H
Bull Soc Sci Med Grand Duche Luxemb; 2010; (2):289-301. PubMed ID: 20882748
[TBL] [Abstract][Full Text] [Related]
54. Lipid-lowering treatment in patients at high cardiovascular risk discharged from an Italian hospital.
Spighi A; Tartagni E; D'Addato S; Dormi A; Borghi C
J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):270-5. PubMed ID: 22728834
[TBL] [Abstract][Full Text] [Related]
55. [Real world use of statins for secondary prevention in patients with high risk coronary heart disease in China].
Li HJ; Liu J; Liu J; Wang W; Qin LP; Li Y; Wang M; Sun JY; Qi Y; Zhao D
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Nov; 38(11):1033-7. PubMed ID: 21215234
[TBL] [Abstract][Full Text] [Related]
56. How many patients need statin treatment in a low-cardiovascular-risk country? Low-density lipoprotein-cholesterol target and distance from target distribution in an Italian cohort.
Poli A; Tragni E; Casula M; Filippi A; Diotti R; Brignoli O; Cricelli C; Catapano AL;
Nutr Metab Cardiovasc Dis; 2012 Apr; 22(4):327-36. PubMed ID: 20884190
[TBL] [Abstract][Full Text] [Related]
57. Statins are less effective in common daily practice among patients with hypercholesterolemia: the REALITY-PHARMO study.
Goettsch WG; Yin DD; Alemao E; Klungel OH; Stalenhoef AF; Herings RM
Curr Med Res Opin; 2004 Jul; 20(7):1025-33. PubMed ID: 15265247
[TBL] [Abstract][Full Text] [Related]
58. A global survey of physicians' perceptions on cholesterol management: the From The Heart study.
Erhardt LR; Hobbs FD
Int J Clin Pract; 2007 Jul; 61(7):1078-85. PubMed ID: 17577295
[TBL] [Abstract][Full Text] [Related]
59. Statin prescription by Croatian family doctors lack of systematic proactive approach to cardiovascular disease prevention.
Vrdoljak D; Bergman Marković B; Kranjcević K
Coll Antropol; 2009 Dec; 33(4):1369-74. PubMed ID: 20102095
[TBL] [Abstract][Full Text] [Related]
60. [Strengthened support for statin therapy as secondary prevention. Doubtful evidence for more intensive lowering of cholesterol levels].
Håkansson J
Lakartidningen; 2011 Jun 1-14; 108(22-23):1234-5. PubMed ID: 21786497
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
